Lapatinib shows minimal effect against liver cancer
Tuesday, September 8, 2009 - 13:49
in Health & Medicine
PHILADELPHIA -- Use of the molecularly targeted agent lapatinib to delay tumor growth and improve the survival of patients with inoperable hepatocellular carcinoma, or liver cancer, only benefited certain subgroups of patients.